EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach

Noor Atatreh, Lana Bustanji, Juliana C Ferreira, Wael M Rabeh, Radwa E Mahgoub iD, Mohammad A Ghattas iD

Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-19

DOI: 10.2147/dddt.s593126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Noor Atatreh und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2, Quinolones, Protease Inhibitors. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsSARS-CoV-2QuinolonesProtease InhibitorsCoronavirus 3C ProteasesCOVID-19 Drug TreatmentMolecular Dynamics SimulationMolecular Docking SimulationStructure-Activity RelationshipHumansPharmacophoreMolecular StructureCoronavirus Papain-Like Proteases

Stichwörter der Autor:innen

dockingenzyme inhibition assaymolecular dynamicspharmacophore filtration

Substanzen

Antiviral AgentsQuinolonesProtease Inhibitorspapain-like protease, SARS-CoV-2Coronavirus 3C ProteasesCoronavirus Papain-Like Proteases

Autor:innen und Institutionen

  • College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates.
  • AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates.
  • Science Division, New York University, Abu Dhabi, 129188, United Arab Emirates.

ORCID-Profile: Radwa E Mahgoub, Mohammad A Ghattas

Zitieren

APA

Atatreh, N., Bustanji, L., Ferreira, J. C., Rabeh, W. M., Mahgoub, R. E., & Ghattas, M. A. (2026). Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach. Drug Design, Development and Therapy, Volume 20, 1-19. https://doi.org/10.2147/dddt.s593126

Vancouver

Atatreh N, Bustanji L, Ferreira JC, Rabeh WM, Mahgoub RE, Ghattas MA. Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach. Drug Design, Development and Therapy. 2026;Volume 20:1-19. doi:10.2147/dddt.s593126

BibTeX
@article{Atatreh2026,
  author = {Atatreh, Noor and Bustanji, Lana and Ferreira, Juliana C and Rabeh, Wael M and Mahgoub, Radwa E and Ghattas, Mohammad A},
  title = {Identification of a Quinolone-Based Scaffold as a Dual SARS-COV-2 PLᵖʳᵒ and Mᵖʳᵒ Inhibitor: An Integrated Molecular Modeling and In-vitro Evaluation Approach},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--19},
  doi = {10.2147/dddt.s593126}
}
Kostenlos starten →